Henryk Klakurka

Corporate Officer/Principal chez PT SOHO Industri Pharmasi

Profil

Henryk Klakurka currently works at Quadria Capital Investment Management Pte Ltd., as Director, PT SOHO Industri Pharmasi, as Director from 2017, and Scholl Plough Canada, Inc., as Vice President-Planning, Distribution & Materials from 1987.
Mr. Klakurka also formerly worked at GenePharm, Inc., as CEO & Regional Director-Americas Merck Generics from 2001 to 2013, Merck Generics Group BV, as Chief Executive Officer from 2003 to 2007, PT SOHO Global Health, as Director, Blue-Zone Technologies Ltd., as Non-Executive Director from 2012 to 2022, Astra Pharma, Inc., as Director-Manufacturing & Logistics from 1987 to 1997, Apotex, Inc., as President from 1997 to 2001, Canadian Pharmaceutical Distribution Network, as Vice President-Operations & Vice President from 1987 to 1997, Novex Pharma, as President from 1997 to 2001, Apotex, Inc., as President, and Schering-Plough Canada, Inc., as Vice President-Manufacturing & Marketing from 1984 to 1987.
Mr. Klakurka received his undergraduate degree in 1972 from the University of Toronto.

Postes actifs de Henryk Klakurka

Sociétés	Poste	Début
PT SOHO Industri Pharmasi	Corporate Officer/Principal	01/01/2017
Quadria Capital Investment Management Pte Ltd.	Private Equity Investor	-

Anciens postes connus de Henryk Klakurka

Sociétés	Poste	Fin
Blue-Zone Technologies Ltd.	Directeur/Membre du Conseil	02/01/2022
GenePharm, Inc.	Directeur Général	01/01/2013
Merck Generics Group BV	Directeur Général	01/01/2007
Novex Pharma	President	01/01/2001
Apotex, Inc.	President	01/01/2001